Stockscreener 앱 받기
34.15
0.41%
0.14
시간 외 거래:
34.14
-0.010
-0.03%
전일 마감가:
$34.01
열려 있는:
$33.97
하루 거래량:
5.36M
Relative Volume:
0.52
시가총액:
$13.21B
수익:
$3.14B
순이익/손실:
$-3.36B
주가수익비율:
-3.9118
EPS:
-8.73
순현금흐름:
$-4.03B
1주 성능:
+9.25%
1개월 성능:
+27.14%
6개월 성능:
-17.53%
1년 성능:
-71.64%
1일 변동 폭
$33.35
$34.44
1주일 범위
$30.88
$35.16
52주 변동 폭
$23.15
$125.68
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
MRNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
34.15 | 13.15B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
How does Moderna Inc. generate profit in a changing economyPhenomenal investment performance - jammulinksnews.com
Moderna's Strategic Position in the EU mRNA Vaccine Landscape: Regulatory Tailwinds and Long-Term Growth Potential - AInvest
Baillie Gifford & Co. Sells 13,941,013 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Down 74% Over the Past Year, Is Moderna Stock a Buy? - Nasdaq
Moderna (NASDAQ:MRNA) Given New $25.00 Price Target at Bank of America - MarketBeat
EU regulator backs Moderna's updated COVID vaccine - Reuters
What analysts say about Moderna Inc. stockUnprecedented market success - PrintWeekIndia
Moderna Inc. Stock Analysis and ForecastRecord-breaking capital gains - PrintWeekIndia
Moderna's mRNA Evolution: Strategic Implications for Biotech and Long-Term Investment - AInvest
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Pfizer/BioNTech, Moderna win EU backing for updated COVID shots - Seeking Alpha
Moderna (MRNA) Advances with Updated Spikevax Vaccine in Europe - GuruFocus
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1 - The Joplin Globe
Moderna's Latest COVID Vaccine Gets EMA Green Light: Targets Dominant LP.8.1 Variant - Stock Titan
What drives Moderna Inc. stock priceSuperior trading gains - Autocar Professional
Universal Beteiligungs und Servicegesellschaft mbH Boosts Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Covid Shot for Kids Cleared in Face of RFK Criticism - MSN
Moderna (MRNA) Expected to Announce Earnings on Friday - MarketBeat
Is Moderna Inc. a good long term investmentOutstanding growth strategies - Autocar Professional
Will Moderna Inc. stock split in the near futureExceptional profit velocity - jammulinksnews.com
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Newport Daily News
Wealthfront Advisers LLC Raises Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
When the Price of (MRNA) Talks, People Listen - news.stocktradersdaily.com
South Dakota Investment Council Cuts Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What's Going On With Moderna Stock Wednesday? - Benzinga
New York State Common Retirement Fund Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Melanoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Algorithm, Pipeline Analysis | IO Biotech, Moderna Inc., Merck Sharp & Dohme LLC, BioNTech SE, TILT Biotherapeutics LLC, Nykode - Barchart.com
Moderna (MRNA) Stock Target Price Lowered by B of A Securities | - GuruFocus
Moderna Target of Unusually High Options Trading (NASDAQ:MRNA) - MarketBeat
Lexicography: Clear And Unequivocal - The National Law Review
Moderna cancels plans to build mRNA manufacturing site in Japan - Endpoints News
After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo - BioSpace
Moderna Bets Big On New Vaccines After Stock Tumbles - Finimize
Edgestream Partners L.P. Buys 71,544 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Equities Analysts Offer Predictions for Moderna Q2 Earnings - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Buys 17,268 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Moderna, Inc. (MRNA) Aktienkurs, Nachrichten, Kurs und Verlauf - yahoo.co
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):